MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 240 filers reported holding MEDIVATION INC in Q1 2014. The put-call ratio across all filers is 1.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $9,045,000 | -59.4% | 150,000 | -69.0% | 0.55% | -55.5% |
Q1 2016 | $22,259,000 | -4.9% | 484,100 | 0.0% | 1.24% | +6.3% |
Q4 2015 | $23,401,000 | +17.8% | 484,100 | +3.6% | 1.17% | +1.4% |
Q3 2015 | $19,865,000 | -16.4% | 467,400 | +124.5% | 1.15% | -10.3% |
Q2 2015 | $23,776,000 | -11.5% | 208,200 | 0.0% | 1.29% | -36.4% |
Q1 2015 | $26,872,000 | +27.8% | 208,200 | -1.4% | 2.02% | -11.9% |
Q4 2014 | $21,028,000 | -22.7% | 211,100 | -23.3% | 2.30% | -39.6% |
Q3 2014 | $27,219,000 | +28.3% | 275,300 | 0.0% | 3.80% | +31.7% |
Q2 2014 | $21,220,000 | +24.6% | 275,300 | +4.1% | 2.89% | +9.2% |
Q1 2014 | $17,026,000 | +97.9% | 264,500 | +96.2% | 2.64% | -0.3% |
Q4 2013 | $8,603,000 | – | 134,800 | – | 2.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,198,919 | $283,814,000 | 82.63% |
BB BIOTECH AG | 1,274,706 | $164,526,000 | 4.90% |
Selkirk Management LLC | 64,300 | $8,299,000 | 4.61% |
Opus Point Partners Management, LLC | 30,747 | $3,969,000 | 3.33% |
Arlington Capital Management, Inc. | 28,845 | $3,723,000 | 2.67% |
Orbimed Advisors | 2,348,900 | $303,173,000 | 2.59% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 70,900 | $9,151,000 | 2.44% |
HealthCor Management, L.P. | 375,000 | $48,401,000 | 2.31% |
BENDER ROBERT & ASSOCIATES | 27,084 | $3,496,000 | 2.04% |
Eventide Asset Management | 208,200 | $26,872,000 | 2.02% |